SEC FORM 4CLUSTER · 2 INSIDERS
$82,650.00
Veraxa Biotech AG - Post de-SPAC (VRXA)
Purchase of 55,000 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
- Antz Christoph Rudiger, Chief Executive OfficerPurchase of 5,000 shares at $1.53 per share.$7,650.00
- Baumann Oliver RolfPurchase of 50,000 shares at $1.50 per share.$75,000.00
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Aug 27, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001829126-26-009543 · filed 2026-08-31 · View filing →
Source: SEC Form 4 · 0001829126-26-009544 · filed 2026-08-31 · View filing →